● Recruiting

A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

Condition: Generalized Myasthenia Gravis (gMG) · gMG · Sponsor: argenx

PhaseN/A

Planned participants100

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study aims to generate real world evidence (RWE) from Italian clinical practice on the impact of efgartigimod alfa in gMG patients encompassing clinical outcomes and patient reported experiences. The study population will consist in adult patients with a documented diagnosis of gMG who are AChR-antibody positive and for whom the decision of treatment with efgartigimod alfa for gMG has been made independently of study participation as part of routine clinical care. The total study duration will be up to 23 months

This description comes directly from the study's public registry record.

Talk to the study team

Sabine Coppieters, MD · 857-350-4834 · clinicaltrials@argenx.com

Always discuss trial participation with your own doctor first.

Locations (30)

Ospedale Generale Regionale F. Miulli	Acquaviva delle Fonti, Italy	Recruiting
Azienda Ospedaliero Universitaria delle Marche	Ancona, Italy	Recruiting
A.O.U. Consorziale Policlinico	Bari, Italy	Recruiting
ASST Papa Giovanni XXIII	Bergamo, Italy	Recruiting
Ospedale Bellaria	Bologna, Italy	Recruiting
A.O.U. Renato Dulbecco	Catanzaro, Italy	Recruiting
A.O.U. Careggi	Florence, Italy	Recruiting
IRCCS Ospedale Policlinico San Martino	Genova, Italy	Recruiting
A.O.U. Policlinico G. Martino	Messina, Italy	Recruiting
IRCCS Cà Granda Ospedale Maggiore Policlinico	Milan, Italy	Recruiting
Ospedale San Raffaele	Milan, Italy	Recruiting
IRCCS Istituto Neurologico Carlo Besta	Milan, Italy	Recruiting

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07595653